Woodstock Corp’s Agios Pharmaceuticals AGIO Stock Holding History

Woodstock Corp’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,443	Closed	-$288K	–	158
2015 Q4	$288K	Hold	4,443	–	–	0.06%	124
2015 Q3	$314K	Hold	4,443	–	–	0.07%	123
2015 Q2	$494K	Hold	4,443	–	–	0.09%	117
2015 Q1	$419K	Hold	4,443	–	–	0.08%	124
2014 Q4	$498K	Hold	4,443	–	–	0.09%	119
2014 Q3	$273K	Buy	+4,443	New	+$192K	0.05%	146

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FVF2

Flagship Ventures Fund 2007 Cambridge, Massachusetts $95.2M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodstock Corp's AGIO Position: Q1 2016 in Review

Woodstock Corp sold out of Agios Pharmaceuticals (AGIO) in Q1 2016, closing a stake of 4,443 shares — an estimated $288K sold.

Woodstock Corp first reported a position in AGIO in Q3 2014 and held it in 6 quarters. The position peaked at $498K in Q4 2014. 157 funds tracked by Wall St. Rank hold AGIO as of Q1 2016.

Woodstock Corp reported no remaining Agios Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Woodstock Corp sold 4,443 Agios Pharmaceuticals shares in Q1 2016, an estimated $288K.
Woodstock Corp first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 6 quarters.
Woodstock Corp's Agios Pharmaceuticals position peaked at $498K in Q4 2014.
157 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2016.

Based on Woodstock Corp's 13F filing for Q1 2016, filed 10 May 2016.